Maria Concetta Petti - European Medicines Agency

advertisement
Curriculum Vitae
PERSONAL INFORMATION
Maria Concetta Petti
WORK EXPERIENCE
November 2012–Present
Consultant
Indipendent professional , (Italy)
Medical advisor
Expert consultant AIFA
Related document(s):
February 2001–November 2012
Head Haematology and Stem cell transplant Unit Unit
Regina Elena Cancer Institute, (Italy)
Responsible for planning and coordinating clinical trials, , responsible for defining and implementing
hematological medical strategy, responsible of policy development and grow of Hematology and
Transplant Unit
Related document(s):
October 1989–January 2001
Senior Assistant Professor
University , (Italy)
Responsible for onco-hematological patients medical assistance, research in early diagnosis, staging,
therapeutic strategy and medical treatment of hematological diseases, medical education of students
Related document(s):
October 1981–October 1989
University research scientist
University , (Italy)
Management of hematological in/out patients, clinical research
Related document(s):
October 1975–October 1981
Scholarship holder
University , (Italy)
Clinical experience in managing patients with hematological diseases
actively involved in clinical and experimental research
Related document(s):
EDUCATION AND TRAINING
November 1966–July 1972
Student Medicine
University , (Italy)
Degree cum laude
Related document(s):
November 1972–November 1975
Registrar
Post graduate school of Hematology University , (Italy)
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 1 / 23
Curriculum Vitae
Maria Concetta Petti
Post graduate Specialty in Hematology cum laue
Related document(s):
May 1979–December 1979
Visitor
Unitè de Haematology, Hopital S. Louis Paris, (France)
training course
Related document(s):
ADDITIONAL INFORMATION
Expertise
Biology of acute leukemias, myeloproliferative disorders and myelodisplastic syndromes
Clinical trials on the role of chemotherapies, BRM's, differentiative agents and growth factors in
leukemias, lymphoproliferative and myeloproliferative disorers, myelodisplastic synrmes.
Publications
1. FISIOPATOLOGIA E TERAPIA DELLE PIASTRINOPENIE.
F. Mandelli, G. Isacchi, M. G. Mazzucconi, M. C. Petti
Accademia Lancisiana di Roma.
Vol. XVII n. 2, 1970
2. LA CINETICA PIASTRINICA VALUTATA CON METODI RADIOISOTOPICI IN SOGGETTI CON
TROMBOCITOPENIA CRONICA IDIOPATICA: RISULTATI DELLA SPLENECTOMIA.
G. Isacchi, M. C. Petti, A. P. Anselmo, F. Mandelli
Atti del XXIV Cong. Soc. Italiana di Ematologia; p. 733-735, 1973.
3. LA RECIDIVA DELLE LEUCEMIE ACUTE NON LINFOIDI: MODALITA' DI INSORGENZA ED
EVOLUZIONE.
M. C. Petti, L. Annino, F. Malagnino, F. Mandelli
Atti del XXIV Cong. Naz. della Soc. Italiana di Ematologia p. 697-704, 1973.
4. ASSISTENZA AMBULATORIALE AL PAZIENTE LEUCEMICO.
F. Mandelli, G. Alimena, P. Babbo, F. Malagnino, A. Montuoro, M. C. Petti
Atti dei Convegni Lincei. Convegno Intern. Nuove Acquisizioni nelle Leucemie e Basi Biologiche delle
Terapie p. 223-228, 1973.
5. L'ASPARAGINASI NELLA POLICHEMIOTERAPIA DELLE LEUCEMIE ACUTE NON LINFOIDI.
F. Mandelli, A. M. De Luca, S. Amadori, G. Mariani, L. Annino, F. Malagnino, M. C. Petti
Atti del XXIV Cong. Naz. della Soc. Italiana di Ematologia p. 692-696, 1973.
6. OCCURENCE, PROPHILAXIS AND THERAPY OF MENINGEAL LEUKEMIA.
F. Mandelli, G. Isacchi, L. Granati, M. C. Petti
Proc Int Meeting “Therapy of Acute Leukemias”, p. 327-335, 1973.
7. UN CASO DI PRIAPISMO IN CORSO DI LEUCEMIA MIELOIDE CRONICA INFANTILE.
P. Babbo, G. Alimena, M. C. Petti
Progresso Medico, vol. XXX, 265-268, 1974.
8. ALCUNI ASPETTI DELLA TERAPIA SOSTITUTIVA CON EMODERIVATI.
F. Mandelli, G. Alimena, L. annino, F. Malagnino, M. C. Petti
Atti del Simposio su "Globuli rossi congelati e terapia con i componenti del sangue"; p.62-84, 1974.
9. UN CASO DI LEUCEMIA LINFOIDE ACUTA A PRIMITIVA LOCALIZZAZIONE RENALE.
G. Alimena, P. Babbo, U. Di Tondo, C. Laurenti, M. C. Petti
Progresso Medico, vol XXX, 522-527,1974.
10. THERAPY IN ACUTE NON LYMPHOID LEUKEMIA RELAPSES.
F. Mandelli, G. De Rossi, G. Isacchi, G. Papa, M. C. Petti
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 2 / 23
Curriculum Vitae
Maria Concetta Petti
Proceeding of the Intern. Conference on Leukemia and Aplastic Anemia; p. 564-567, 1974.
11. RISULTATI PRELIMINARI DEL PROTOCOLLO SECONDO BURKE E OWENS (1971) NELLE
LEUCEMIE ACUTE NON LINFOIDI IN RECIDIVA.
A. M. De Luca, F. Malagnino, M. C. Petti, S. Amadori, G. Papa, F. Mandelli
Atti del XXV Cong. della Soc. Italiana di Ematologia; p. 494-502, 1975.
12. LACK OF PROGNOSTIC SIGNIFICANCE OF PRETREATMENT LABELING AND MITOTIC
INDICES OF MARROW BLASTS IN ACUTE NON LYMPHOCYTIC LEUKEMIA (ANLL).
S. Amadori, M. C. Petti, A. De Francesco, A. Chierichini, C. Mastrovincenzo, M. G. Testa, F. Mandelli
Cancer 41, 1154-1160, 1978
13. CELL KINETICS AND PROGNOSIS IN ACUTE NON LYMPHOCYTYC LEUKEMIA.
Amadori, M. C. Petti, M. Persiani, C. Mastrovincenzo, M. G. Testa, F. Mandelli
In “Therapy of Acute Leukemias”, Lombardo Editore; 127-134; 1978.
14. TREATMENT OF ACUTE NON LYMPHOCYTIC LEUKEMIA (ANLL) IN ELDERLY PATIENTS.
RESULT OF A MULTICENTRIC STUDY.
F. Mandelli, S. Amadori, F. Fabiani, F. Grignani, V. Liso, M. Martelli, A. Neri, M. C. Petti, M. Tonato
Haematologica vol. 64, n. 3, 331-338, 1979
15. DRUG INDUCED KINETIC PERTURBATIONS OF THE MARROW BLASTS IN ACUTE
LEUKEMIA. EECT OF DAUNORUBICIN, CYTOSINE, ARA-BINOSIDE AND 6-THIOGUANINE
COMBINATION.
S. Amadori, M. C. Petti, C. Mastrovincenzo, M. G. Testa
Acta Haematologica 61, 237-242, 1979.
16. TERAPIA DELLE LEUCEMIE ACUTE NON LINFOIDI DELL'INFANZIA (STUDIO DI 60
PAZIENTI).
M. C. Petti, S. Amadori, L. Pacilli, F. Mandelli
Acta Paediatrica Latina vol. XXXII, (Suppl. 4), 779-789; 1979.
17. BLAST CELL KINETICS AND PROGNOSIS IN ACUTE NON LYMPHOCYTIC LEUKEMIA.
S. Amadori, M. C. Petti, C. Mastrovincenzo, M. G. Testa, A. Antonelli, F. Mandelli
Leukemia Research 4: 239-244, 1980.
18. CYTOKINETIC STUDIES IN CHRONIC LYMPHOCYTIC LEUKEMIA. RELATIONSHIP TO
OTHER VARIABLES AT DIAGNOSIS AND SURVIVAL.
M. C. Petti, M. G. Testa, G. Deb, S. Amadori
Biomedicine 33, 188-190, 1980.
19. THERAPY OF ACUTE NONLYMPHOCYTIC LEUKEMIA IN CHILDREN: A REVIEW OV 73
PATIENTS.
S. Amadori, M. C. Petti, L. Pavilli, G. Papa, F. Mandelli
Tumori 67, 209-214, 1981.
20. RANDOMIZED CLINICAL TRIAL OF IMMUNOTHERAPY AND ANDROGENO-THERAPY FOR
RIMISSION MAINTENANCE IN ACUTE NONLYMPHOCYTIC LEUKEMIA.
F. Mandelli, S. Amadori, E. Dini, F. Grignani, P. Leoni, V. Liso, M. Martelli, A. Neri, M. C. Petti, P. Rossi
Ferrini
Leukemia Research 5,447-452, 1981.
21. COMPARAZIONE DELLE ASSOCIAZIONI CEFAMANDOLO+TOBRAMICINA E
CARBENICILLINA+SISOMICINA NELLE COMPLICANZE INFETTIVE DI PAZIENTI EMOPATICI.
ESPERIENZA CLINICA E DI LABORATORIO.
M. Venditti, P. Martino, M. C. Petti, F. Mandelli, P. Serra
Chemioterapia antimicrobica 2, 147-155, 1981.
22. CLINICAL AND BIOLOGICAL ASPECTS OF ACUTE MONOCYTIC LEUKEMIA.
M. C. Petti, S. Amadori, W. Arcese, G. Avvisati, A. Di Lorenzo, R. Gastaldi, F. Mandelli
Haematologica 67, 556-566, 1982.
23. LA TERAPIA DELLE LEUCEMIE ACUTE NON LINFOIDI.
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 3 / 23
Curriculum Vitae
Maria Concetta Petti
F. Mandelli, M. C. Petti, P. Martino, G. Deb, W. Arcese, G. Avvisati
EOS 2, 15-20, 1982.
24. APPROCCIO DIAGNOSTICO E TERAPEUTICO DELLE INFEZIONI (ESPERIENZA DELLA
CATTEDRA DI EMATOLOGIA DI ROMA).
M. C. Petti, P. Martino, M. Ciuffreda, T. Gallerano, M. Venditti
Atti dell'8^ Corso Nazionale di Aggiornamento in Ematologia Clinica 213 231 Brisighella, 1982.
25. CITOFLUORIMETRIA A FLUSSO: PRINCIPI DI TECNICA ED APPLICAZIONI IN BIOLOGIA.
G. Grandori, M. G. Testa, M. C. Petti, S. Amadori
Progressi in Medicina 38, 79-85, 1982.
26. LONG TERM SURVIVAL IN ADULT ACUTE LEUKEMIA. A MULTICENTRIC STUDY OF 56
PATIENTS.
S. Tura, M. Gobbi, M. Cavo, G. Bachetti, F. Mandelli, S. Amadori, M. C. Petti, N. Quattrin, L. De Rosa,
E. Storti, S. C. Rizzo, C. Bernasconi, L. Salvaneschi, W. Paolino, V. Infelise, E. Dini, T. Barbui, L.
Bruzzese, A. Abbadessa, M. F. Martelli, P. Rambotti
Haematologica 67, 368-383, 1982.
27. LE FORME IPERLEUCOCITARIE E TUMORALI DELLE LEUCEMIE ACUTE: STORIA
NATURALE E STRATEGIA TERAPEUTICA.
G. Papa, M. A. Aloe Spiriti, S. Fenu, F. Giona, M. C. Petti, G. Meloni, F. Malagnino
Atti del IV Congresso Nazionale della Societa' Italiana di terapia intensiva.
Napoli 19-20 novembre 1982.
28. CEFOTAXINE+AMIKACINA NEL TRATTAMENTO DELLE COMPLICANZE INFETTIVE DEI
PAZIENTI EMOPATICI: ESPERIENZA CLINICA E DI LABORATORIO.
M. Venditti, B. Valente, M. C. Petti, T. Gallerano, P. Martino
BML 4, 29-38, 1982.
29. MIELOFIBROSI: SINTOMATOLOGIA.
M. C. Petti, G. Avvisati, G. Di Nucci, S. Fenu, M. Allo'
IX Corso Nazionale di Aggiornamento in Ematologia Clinica, p. 285-307, 1983.
30. CEFTAZIDIME+AMIKACINA NEL TRATTAMENTO DI INFEZIONI GRAVI IN PAZIENTI
NEUTROPENICI. ESPERIENZA CLINICA E DI LABORATORIO.
M. Venditti, C. Santini, S.Fenu, M. C. Petti, A. Pulsoni, P. Martino
Progressi in Chemioterapia 30, 393-400, 1983
31. CARATTERIZZAZIONE CITOCINETICA DELLE LEUCEMIE ACUTE: ASPETTI BIOLOGICI ED
IMPLICAZIONI TERAPEUTICHE.
M. C. Petti, M. G. Testa, S. Amadori
Oncoematologia, atti XXIX Settimana Medica degli Ospedali 33-38; 1984.
32. SEQUENTIAL COMBINATION OF HIGH DOSE ARA-C (HiDAC) AND ASPARAGINASE (ASP)
FOR THE TREATMENT OF ADVANCED ACUTE LEUKEMIA AND LYMPHOMA.
S. Amadori, G. Papa, G. Avvisati, S. Fenu, B. Monarca, M. C. Petti, A. Pulsoni, F. Mandelli
Leukemia Research 8, 729-735, 1984.
33. COTRIMOXAZOLE PROFILAXIS IN PATIENTS WITH LEUKEMIA AND PROLONGED
GRANULOCYTOPENIA.
P. Martino, M. Venditti, M. C. Petti, F. Mandelli, P. Serra
Am J Med Science 287-289, 1984.
34. CONSIDERAZIONI CLINICHE IN DUE CASI DI NEOFORMAZIONE MALIGNA A CARICO DEL
MASCELLARE.
M. Barbara, M. C. Petti, F. Malchiodi, L. Urbani
Rivista Italiana di Otorinolaringologia Andiologia e Foniatria, 4, 139-142, 1984.
35. SEQUENTIAL COMBINATION OF SYSTEMIC HIGH DOSE ARA-C AND ASPARAGINASE FOR
THE TREATMENT OF CENTRAL NERVOUS SYSTEM LEUKEMIA AND LYMPHOMA.
S. Amadori, G. Papa, G. Avvisati, M. C. Petti, M. Motta, M. L. Salvagnini, G. Meloni, M. Martelli, B.
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 4 / 23
Curriculum Vitae
Maria Concetta Petti
Monarca, F. Mandelli
J. Clin. Oncol. 2, 98-101, 1984.
36. FATTORI PROGNOSTICI E IMPLICAZIONI TERAPEUTICHE NELLE LEUCEMIE ACUTE.
F. Mandelli, M. A. Aloe Spiriti, G. Meloni, M. C. Petti
In Leucemie e Linfomi Casa Ed. Ambrosiana, Milano 1984
37. CEFOTAXIME PLUS AMIKACIN AS EMPIRIC THERAPY IN TREATMENT OF FEBRILE
EPISODES IN NEUTROPENIC PATIENTS WITH HEMATOLOGIC MELIGNANCIES.
P. Martino, M. Venditti, M. C. Petti, F. Mandelli, P. Serra
Infection 13,125-129, 1985
38. LYMPHOCYTE SUBPOPULATTIONS AND CELL MEDIATED CYTOTOXICITY IN ACUTE
NONLYMPHOID LEUKEMIA (ANLL) PATIENTS IN COMPLETE REMISSION (CR) AND OFFTHERAPY
G. De Rossi, L. Fontana, G. de Santis, M. C. Petti, D. Pasqualetti, C. Guglielmi, A. Vitale, F. Mandelli.
Biomedicine & Pharmacotherapy 39, 245-247, 1985
39. LA TERAPIA DELLA LEUCEMIA ACUTA DELL'ANZIANO
F. Mandelli, M. C. Petti, M. A. Aloe Spiriti, S. Fenu, S. Giona, A. Tafuri
Giornale di Gerontologia 23, 749-759, 1985
40. ACUTE PROMYELOCYTIC LEUKEMIA: CLINICAL ASPECTS AND RESULTS OF TREATMENT
IN 62 PATIENTS.
M.C.Petti, G. Avvisati, S.Amadori, M. Baccarani, A.R. Guarini, G.Papa, G.A. Rosti, S.Tura, F. Mandelli
Haematologica 72; 151-155; 1987
41. AUTOLOGOUS BONE MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE
MYELOGENOUS LEUKEMIA IN COMPLETE REMISSION
G. Meloni, P. De Fabritiis, M. C. Petti, A. Pulsoni, A Sandrelli, A. Covelli, F. Simone, F. Mandelli
Ann NY Acad Sc 511, 483-488; 1987
42. LA CHEMIOTERAPIA DELLE LEUCEMIE ACUTE NON LINFOIDI
F. Mandelli, M. C. Petti, M. A Aloe Spiriti
Haematologica 72 (supp) 121-127; 1987
43. MOTILITY AND OXIDATIVE METABOLISM OF NORMAL POLYMORPHONUCLEAR
LEUKOCYTES IN ACUTE NON-LYMPHOID LEUKEMIA IN COMPLETE REMISSION.
Bottari, A. Fattorossi, R. Nisini, M.C. Petti, S. Fenu, L. Fontana
La Ricerca Clin Lab 17; 41-46; 1987.
44. SEQUENTIAL PILOT STUDIES OF INTENSIVE POST-REMISSION CHEMOTHERAPY FOR
ACUTE NONLYMPHOCYTIC LEUKEMIA
M. C. Petti, G. Avvisati, A. Tafuri, G. Meloni, S. Amadori, F. Mandelli
Ann New York Ac of Sc 511, 436-441, 1987
45. AN ITALIAN MULTICENTER PHASE III TRIAL OF IDARUBICIN PLUS CYTARABINE VS
DAUNORUBICIN PLUS CYTARABINE IN ELDERLY PATIENTS WITH ACUTE NON-LYMPHOID
LEUKEMIA
L. Resegotti, F. Mandelli, S. Amadori, L. Bruzzese, C. De Rosa, F. Di Raimondo, N. Di Pietro, E.
Geraci, G. Leone, C. Malleo, A. Neri, L. Pacilli, M. C. Petti, S. Fenu, G. Specchia, A. Tabilio and the
Italian Cooperative Group GIMEMA
In Mandelli F.& Al: Idarubicin in the treatment of acute leukemia, Excepta Medica, Amsterdam, 1987 p.
42-49
46. ACQUIRED ALPHA-2-ANTIPLASMIN DEFICIENCY IN ACUTE PROMYELOCYTIC
LEUKAEMIA
G. Avvisati, J. Ten Cate, A. Sturk, R. Lamping, M.C. Petti, F. Mandelli
Br J Haematol 70, 43-48, 1988
47. PHASE II STUDY OF INTERMEDIATE DOSE ARA-C (IDAC) AND MITOXANTRONE (MITOX)
FOR ACUTE MYELOGENOUS LEUKEMIA
S. Amadori, F. Mandelli, G. Meloni, M.C. Petti, R. Miniero, G. Papa
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 5 / 23
Curriculum Vitae
Maria Concetta Petti
New Trends Ther Leuk Lymph 3, 17-22, 1988
48. AUTOLOGOUS BONE MARROW TRANSPLANTATION (ABMT) IN AML PATIENTS IN
SECOND COMPLETE REMISSIONS (CR)
G. Meloni, P. De Fabritiis, A. Pulsoni, A. Sandrelli, V. Giarnieri, A. Covelli, M.C. Petti,A. M. Testi, F.
Mandelli
T Cell Depletion in Allog. Bone Marrow Transpl., Reisner Ed., 191-195, 1988
49. ACUTE NON LYMPHOID LEUKEMIA TREATMENT: AN UPDATE.
F. Mandelli, M.C. Petti, M.A. Aloe Spiriti
Haematologica 73,1-6 1988
50. KIDNEY CARCINOMA REVEALED BY AUTOIMMUNE HEMOLYTIC ANEMIA
G. Girelli, G. Adorno, P. Perrone, M.C. Arista, A. Cardillo, M.L. Vegna, M.C. Petti, F. Mandelli
Haematologica 73; 309-11 1988
51. INSORGENZA DI ANEMIA EMOLITICA AUTOIMMUNE IN CORSO DI SINDROME
MIELODISPLASTICA. OSSERVAZIONI DI 3 CASI
C. Sgadari, R. Latagliata, E. Falconi, P. Perrone, M. C. Petti, G. Girelli
Riv. Emoter. Immunoemat., 35, 39-45, 1988
52. HIGH-DOSE ARA-C (HIDAC) PLUS ASPARAGINASE IN ELDERLY PATIENTS WITH ACUTE
NON-LYMPHOCYTIC LEUKEMIA: A PILOT MULTICENTRIC STUDY BY THE ITALIAN
COOPERATIVE GROUP GIMEMA.
M.C. Petti, F. Mandelli, G. Avvisati, A. Covelli, S. Amadori, V. Liso, G. Leone, A. De Laurenzi, P. Leoni,
A. Neri, F. Grignani, G. Torlontano, L. Deriu, F. Caronia
Eur J Haematol 42;24-31, 1989
53. ACUTE NONLYMPHOCYTIC LEUKEMIA IN THE ELDERLY: RESULTS OF A
RETROSPECTIVE STUDY
R. Latagliata, C. Sgadari, F. Pisani, M. Falconi, A. Spadea, M.L. Vegna e M.C. Petti
Haematologica 74, 167-171, 1989
54. IDARUBICIN IN ACUTE LEUKEMIAS: EXPERIENCE OF THE ITALIAN COOPERATIVE
GROUP GIMEMA
M. C. Petti, F. Mandelli
Sem Oncol 16, 10-15 1989
55. LEUCEMIA ACUTA MONOCITICA
F. Mandelli, M. C. Petti, M. A. Aloe Spiriti, R. Latagliata
in "Progressi in Ematologia Clinica", vol. VIII, Monocito Macrofago, p. 137-141, 1989
56. LEUCEMIA MIELOIDE ACUTA: FATTORI PROGNOSTICI
M. C. Petti, M. A. Aloe Spiriti, R. Latagliata, A. Spadea, M. C. Tirindelli, M. L. Vegna
Haematologica 74 (suppl.5), 380-391, 1989
57. ACUTE NON LYMPHOID LEUKEMIA TREATMENT: AN UPDATE
F. Mandelli, R. Latagliata, M.C. Petti
In "Infectious and haemorrhage in acute leukemia" T. Barbui et al (edts), John Libbey Eurotext, Paris
p.1-6, 1989
58. TREATMENT OF RECURRENT PROMYELOCYTIC LEUKEMIA WITH A COMBINATION
REGIMEN UTILIZING AMSACRINE, CYTOSINE ARABINOSIDE AND 6-THIOGUANUNE (AAT)
G. Avvisati, M. C. Petti, M. T. Petrucci, E. Falconi, M. C. Tirindelli, F. Mandelli
Haematologica 74, 279-282; 1989
59. INTENSIFICATION IN POST-REMISSION TREATMENT OF ADULT ACUTE NON
LYMPHOCYTIC LEUKEMIA
M. C. Petti, M. A. Aloe Spiriti, A. M. Carella, G. Fioritoni, L. Resegotti, V. Rizzoli, A. Tabilio, G. Visani,
M.L. Vegna, F. Mandelli.
Haematologica 74, 267-271; 1989
60. PHASE II TRIAL OF INTERMEDIATE DOSE ARA-C (IDAC) WITH SEQUENTIAL
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 6 / 23
Curriculum Vitae
Maria Concetta Petti
MITOXANTRONE (MITOX) IN ACUTE MYELOGENOUS LEUKEMIA
S. Amadori, G. Meloni, M. C. Petti, G. Papa, R. Miniero, F. Mandelli
Leukemia 3, 112-114, 1989
61. DEFICIENCY OF LYMPHOCYTE LECTIN-DEPENDENT CYTOTOXICITY IN
MYELODISPLASTIC SYNDROMES
L. Fontana, G. De Santis, G. De Rossi, V. Bottari, M.C. Petti, F. Ensoli, D. Pasqualetti, F. Mandelli
Acta Haemat. 82, 1-6; 1989
62. IDARUBICIN IN ACUTE LEUKEMIA
F. Mandelli, L. Annino, G. Avvisati,F. Giona, G. Meloni, M.C. Petti, A.M. Testi, A.M. Carella, F. Caronia,
M. Carotenuto, A. Ceci, P. Leoni, V. Liso, E. Madon, L. Resegotti, L. Zanesco GIMEMA Group.
Bone Marrow Transplantation 4 (suppl.3),49-52 1989
63. DEFECTIVE ANTIBODY-DEPENDENT AND LECTIN-INDUCED POLYMORPHONUCLEAR
CYTOTOXICITY IN PATIENTS WITH MYELODISPLASTIC SYNDROMES
L. Fontana, G. De Santis, V. Bottari, M. C. Petti, F. Mandelli
Haematologica 75, 46-49; 1990
64. BLASTOSCHIZOMICES CAPITATUS: AN EMERGING CAUSE OF INVASIVE FUNGAL
DISEASE IN LEUKEMIA PATIENTS
P. Martino, M. Venditti, A. Micozzi, G. Morace, L. Polonelli, M. Pettoello Mantovani, M. C. Petti, V. L.
Burgio, C. Santini, P. Serra, F. Mandelli
Rev Inf Dis 12, 570-582; 1990
65. IDARUBICIN (4-DEMETHOXYDAUNORUBICIN) AS SINGLE AGENT FOR REMISSION
INDUCTION OF PREVIOUSLY UNTREATED ACUTE PROMYELOCYTTIC LEUKEMIA: A PILOT
STUDY OF THE ITALIAN COOPERATIVE GROUP GIMEMA
G. Avvisati, F. Mandelli, M.C. Petti, M.L. Vegna, A. Spadea, V. Liso, G. Specchia, C. Bernasconi, E.P.
Alessandrino, C. Piatti, A.M. Carella
Eur J Haematol 44, 257-260; 1990
66. UN VECCHIO E NUOVO CITOTOSSICO: IL BISANTRENE
M. C. Petti, M. A. Aloe Spiriti, R. Latagliata, M. C. Tirindelli, S. Amadori
XVI Corso Nazionale di Aggiornamento in Ematologia Clinica, Bologna 4-6 giugno 1990, p. 295-307.
67. BAVC REGIMEN AND AUTOLOGOUS MARROW TRANSPLANTATION IN PATIENTS WITH
ACUTE MYELOGENOUS LEUKEMIA IN SECOND REMISSION
G Meloni, P De Fabritiis, M.C. Petti and F Mandelli
Blood 75, 2282-2285; 1990
68. THERAPY OF ACUTE MYELOGENOUS LEUKEMIA IN ADULTS
M.C. Petti, G. Broccia, F. Caronia, F. Di Raimondo, G. Fioritoni, S. Ladogana, G. Leone, V. Liso, M.
Musso, A. Neri, A. Peta, N. Petti, L. Resegotti, A. Tabilio, M.L. Vegna and F. Mandelli
In "Acute Leukemias II", T. Buchner, G. Schellong, W. Hiddeman, J. Ritter (Eds); Springer-Verlag,
1990
69. HIGH DOSES OF ARA-C AND m-AMSA IN THE TREATMENT OF REFRACTORY ACUTE NON
LYMPHOCYTIC LEUKEMIA
R. Latagliata, M.C. Petti, M.A. Aloe Spiriti, G. Meloni, C. Sgadari, C. Torromeo, M.L. Vegna, F. Mandelli
Haematologica 75, 249-251; 1990
70. MYELOFIBROSIS WITH MYELOID METAPLASIA: CLINICAL AND HAEMATOLOGICAL
PARAMETERS PREDICTING SURVIVAL IN A SERIES OF 133 PATIENTS
G. Visani, C. Finelli, U. Castelli, M.C. Petti, P. Ricci, N. Vianelli, L. Gianni, E. Zuffa, M.A. Aloe Spiriti, R.
Latagliata, S. Pileri, U. Magrini, L. Gugliotta, E. Morra, C. Bernasconi, F. Mandelli and S. Tura
Brit J Haematol 75, 4-9; 1990
71. INTERLEUKIN-1 AND INTERLEUKIN-2 CONTROL GRANULOCYTE- AND GRANULOCYTEMACROPHAGE COLONY-STIMULATING FACTOR GENE EXPRESSION AND CELL
PROLIFERATION IN CULTURED ACUTE MYELOBLASTIC LEUKEMIA
F. Cozzolino, M. Torcia, S. Bettoni, D. Aldinucci, V.L. Burgio, M.C. Petti, A. Rubatelli, T. Barbui and A.
Rambaldi Int J Cancer 46, 902-907, 1990
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 7 / 23
Curriculum Vitae
Maria Concetta Petti
72. GIMEMA EXPERIENCE IN THE TREATMENT OF ADULT ACUTE MYELOGENOUS
LEUKEMIA
F. Mandelli, M.C. Petti, G. Avvisati, S. Amadori, G. Broccia, A.M. Carella, M. Carotenuto, F. Di
Raimondo, G. Fioritoni, M. Lazzarino, G. Leone, M. Martelli, S. Mirto, A. Peta, N. Petti, L. Resegotti, G.
Specchia, M.L. Vegna, for the Cooperative Group GIMEMA, Italy
In: Acute Myelogenous Leukemia. Progress and Controversies, p.273-291 1990 Wiley-Liss, Inc.
73. TRANSIENT SPONTANEOUS REMISSION IN A CASE OF ADULT ACUTE MYELOGENOUS
LEUKEMIA
A. Spadea, R. Latagliata, E. Martinelli and M.C. Petti
Brit J Haematol 76, 154, 1990
74. TRATTAMENTO POST-REMISSIONE DELLA LEUCEMIA MIELOIDE ACUTE
F. Mandelli, G. Meloni, G. Arcese, M.C. Petti
XI Corso di Aggiornamento in Ematologia Pavia, 4-5 Ottobre 1990 p.155-174
75. LEUCEMIE ACUTE
F. Mandeli, M.C. Petti
In: A. Santoro, G. Bonadonna "Terapia Medica Oncologica 1990" p. 149-174 SES Napoli, 1990
76. BAVC FOLLOWED BY UNPURGED MARROW IN II CR AML PATIENTS
Meloni G, Vignetti M, De Fabritiis P, Foa R, Petti MC, Pinto R, Rolla M, Mandelli F.
In "Autologous Bone Marrow Transplantation" Proc. Fifth Int Symposium, August 1990
77. SERUM INTERLEUKIN-2 (IL-2), SOLUBLE IL-2 RECEPTORS AND TUMOR NECROSIS
FACTOR-ALFA LEVELS ARE SIGNIFICANTLY INCREASED IN ACUTE MYELOID LEUKEMIA
PATIENTS
G. Cimino, S. Amadori, M.C. Cava, V. De Santis, M.C. Petti, A. O. Di Gregorio, C. Sgadari, L. Vegna,
G. Cimino and F. Mandelli
Leukemia 5, 32-35; 1991
78. RECIPROCAL TRANSLOCATION INVOLVING 3q21 IN AN UNUSUAL
MYELOPROLIFERATIVE DISORDER WITH MYELODISPLASTIC FEATURES AND PROMINENT
DYSMEGACARYOPOIESIS
M. Cedrone, C. Mecucci, V.L. Burgio, D. Diverio, M.C. Petti and G. Alimena
Cancer Genet Cytogenet 51, 73-78; 1991
79. BAVC REGIMEN IN CR AML PATIENTS
Meloni G, Vignetti M, De Fabritiis P, Petti MC, Pinto MR, Testi AM, Vegna ML, Mandelli F
Bone Marrow Transpl 7, (suppl 2)134-35; 1991
80. CHEMIOTERAPIA INTENSIVA DELLE SINDROMI MIELODISPLASTICHE
M.A. Aloe Spiriti, M.C. Petti, R. Latagliata e F. Mandelli
In "Progressi in Ematologia Clinica", vol. X "Sindromi Mielodisplastiche" p.193-199; 1991
81. MOLECULAR EVALUATION OF REPONSE TO ALL-TRANS-RETINOIC ACID THERAPHY IN
PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA
F. Lococo, G. Avvisati, D. Diverio, M.C. Petti, M. Alcalay, P.P. Pandolfi, D. Zangrilli, A. Biondi, A.
Rambaldi, M.L. Moleti, F. Mandelli and P.G. Pelicci
Blood 77, 1657-1659; 1991
82. A RANDOMIZED CLINICAL TRIAL COMPARING IDARUBICIN AND CYTARABINE TO
DAUNORUBICIN AND CYTARABINE IN THE TREATMENT OF ACUTE NONL-YMPHOID
LEUKAEMIA
F. Mandelli, M.C. Petti, A. Arbia, N. Di Pietro, F. Di Raimondo, F. Ganzina, E. Falconi, E. Geraci, S.
Ladogana, R. Latagliata, C. Malleo, F. Nobile, N. Petti, B. Rotoli, G. Specchia, A. Tabilio and L.
Resegotti
Eur J Cancer 27, 750-755; 1991
83. MITOXANTRONE, ETOPOSIDE, AND INTERMEDIATE-DOSE CYTARABINE: AN EFFECTIVE
AND TOLERABLE REGIMEN FOR THE TREATMENT OF REFRACTORY ACUTE MYELOID
LEUKEMIA
S. Amadori, W. Arcese, G. Isacchi, G. Meloni, M.C. Petti, B. Monarca, A.M. Testi and F. Mandelli
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 8 / 23
Curriculum Vitae
Maria Concetta Petti
J Clin Oncol 9, 1210-1214; 1991
84. CD9 ANTIGEN ON ACUTE NON-LYMPHOID LEUKEMIA CELLS: PREFERENTIAL
EXPRESSION BY PROMYELOCYTIC (M3) SUBTYPE
D. Ferrero, N. Carlesso, E. Gallo, P. Pregno, P. De Fabritiis, M.C. Petti and F. Mandelli
Leukemia Res 15, 457-461; 1991
85. REARRANGEMENTS OF THE RAR-a GENE IN ACUTE PROMYELOCYTIC LEUKEMIA:
CORRELATIONS WITH MORPHOLOGY AND IMMUNOPHENOTYPE
F. Lo Coco, G. Avvisati, D. Diverio, A. Biondi, P.P. Pandolfi, M. Alcalay, G. De Rossi, M.C. Petti, A.
Cantù-Rajnoldi, D. Pasqualetti, M. Nanni, S. Fenu, M. Frontani, F. Mandelli
Br J Haematol 78, 494-499; 1991
86. THYMOPENTIN IN THE TREATMENT OF MYELODISPLASTIC SYNDROMES
R. Latagliata, M.C. Petti, M.A. Aloe Spiriti, M.C. Tirindelli, P. Fazi, C. De Gregoris, F. Mandelli
Acta Haematol 86, 115; 1991
87. IN VIVO EFFECT OF GRANULOCYTE-MACROPHAGE COLONY+STIMULATING FACTOR
ON THE KINETICS OF HUMAN ACUTE MYELOID LEUKEMIA CELLS
M. Aglietta, L. De Felice, A. Stacchini, M.C. Petti, A.C.M. Bianchi, M.A. Aloe Spiriti, F. Sanavio, F. Apra,
W. Piacibello, A.C. Stern, F. Gavosto, F. Mandelli
Leukemia 5, 979-984; 1991
88. INTENSIVE CONSOLIDATION CHEMOTHERAPY VERSUS STANDART CONSOLIDATION
MAINTENANCE IN ACUTE MYELOGENOUS LEUKEMIA (AML) IN FIRST REMISSION; AN
EORTC/GIMEMA PHASE III TRIAL (AML8 B)
R. Zittoun, V. Liso, F. Mandelli, B. Rotoli, T. de Witte, C. Gattringer, L. Resegotti, F. Caronia, P. Leoni,
M. C. Petti, G. Solbu, M. L. Vegna, S. Suciu
Leukemia 6 (suppl 2), 76-77; 1992
89. ALLOGENEIC VERSUS AUTOLOGOUS BONE MARROW TRANSPLANTATION (BMT)
VERSUS INTENSIVE CONSOLIDATION IN ACUTE MYELOGENOUS LEUKEMIA (AML) IN FIRST
REMISSION. AN EORTC/GIMEMA PHASE III TRIAL (AML8 A)
R. Zittoun, F. Mandelli, R. Willemze, T. de Witte, S. Tura, P. Ferrini, P. Stryckmans, C. Gattringer, M. C.
Petti, G. Solbu, M. L. Vegna, S. Suciu
Leukemia 6 (suppl 2), 114-115; 1992
90. A RANDOMIZED STUDY OF THE EFFICACY OF POST-CONSOLIDATION THERAPY IN
ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA: A REPORT O THE ITALIAN COOPERATIVE
GROUP GIMEMA
F. Mandelli, M.L. Vegna, G. Avvisati, S. Amadori, A. Spadea, E. Cacciola, N. Cantore, A. De Laurenzi,
C. De Rosa, G. Fioritoni, A. Gabbas, V. Liso, C. Malleo, E. Miraglia, M. Montillo, R. Perricone, A.
Peta, . Ricciuti and M. C. Petti
Ann Hematol 64, 166-172; 1992
91. LEUCEMIE ACUTE
M. C. Petti
In "Leucemie acute e croniche" , p. 1-30, Il Pensiero Scientifico Editore 1992
92. LA POLICITEMIA VERA: ATTUALITA' E PROSPETTIVE
G. Papa, M.C. Petti, R. Stasi, F. Mandelli
In "Progressi in Ematologia Clinica", vol. XI "Leucemie croniche '92", p. 281-293; 1992
93. LEUCEMIE ACUTE
F. Mandelli, M.C. Petti
In: A; Santoro, G. Bonadonna "Terapia Medica Oncologica 1992", p. 141-159; EdiSES Napoli, 1992
94. IDENTIFICATION OF DNA REARRANGMENTS AT THE RETINOIC ACID RECEPTOR-a(RARa) LOCUS IN ALL PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) AND MAPPING
OF APL BREAKPOINTS WITHIN THE RAR-a SECOND INTRON
Diverio D, Lo Coco F, D'Adamo F, Biondi A, Fagioli M, Grignani F, Rambaldi A, Rossi V, Avvisati G,
Petti MC, Testi AM, Liso V, Specchia G, Fioritoni G, Recchia A, Frassoni F, Ciolli S, Pellicci PG.
Blood 79, 3331-3336; 1992
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 9 / 23
Curriculum Vitae
Maria Concetta Petti
95. MOLECULAR EVALUATION OF RESIDUAL DISEASE AS A PREDICTOR OF RELAPSE IN
ACUTE PROMYELOCYTIC LEUKAEMIA
Lo Coco F, Diverio D, Pandolfi PP, Biondi A, Rossi V, Avvisati , Rambaldi A, Arcese W, Petti MC,
Meloni , Mandelli F, Grignani F, Masera G, Barbui T, Pelicci PG
Lancet 340, 1437-1438; 1992
96. RECOMBINANT HUMAN ERYTHRIPOIETIN IN THE TREATMENT OF MYELODYSPLASTIC
SYNDROMES
M. A Aloe Spiriti, M. C. Petti, R. Latagliata, G. Avvisati, C. De Gregoris, S. Proia, P. Fazi, G. Yaalouk,
M. Mancini, A. Spadea, R. Villa, F. Mandelli
In "Erythropoietin Symposium 1992" eds M. Cazzola, G. Barosi, E. Ascari; p.63-66, 1992
97. DO HAEMPOIETIC GROW FACTORS INCREASE THE EFFICACY OF AGGRESSIVE
THERAPY OF ANLL IN ELDERLY PATIENTS?
Mandell F, Petti MC
Hematol Oncol 11, (suppl 1) 9-11; 1993
98. BISANTRENE IN RELAPSED AND REFRACTORY ACUTE MYELOGENOUS LEUKEMIA
A. Spadea, M.C. Petti, M. A. Aloe Spiriti, G. Avvisati, C. De Gregoris, P. Fazi, R. Latagliata, S. Amadori,
F. Mandelli
Leukemia & Lymphoma 9, 217-220, 1993
99. THE SURGICAL CHOISE IN NEUTROPENIC PATIENTS WITH HEMATOLOGICAL
DISORDERS AND ACUTE ABDOMINAL COMPLICATIONS
Chirletti P, Barillari P, Sammartino P, Cardi M, Caronna R, Arcese W, Petti MC, Stipa V
Leukemia & Lymphoma 9, 237-241, 1993
100. IS RECOMBINANT HUMAN ERYTHRIPOIETIN TREATMENT IN MYELODYSPLASTIC
SYNDROMES WORTHWHILES?
M. A Aloe Spiriti, M. C. Petti, R. Latagliata, G. Avvisati, C. De Gregoris, S. Proia, P. Fazi, G. Yaalouk,
M. Mancini, A. Spadea, R. Villa, F. Mandelli
Leukemia & Lymphoma 9, 79-83, 1993
101. PILOT STUDY OF 5-AZA-2'-DEOXYCYTIDINE (DECITABINE) IN THE TREATMENT OF
ACUTE MYELOGENOUS LEUKEMIA PATIENTS: PRELIMINARY RESULTS
M.C. Petti, F. Mandelli, V. Zagonel, C. De Gregoris, M.C. Merola, R. Latagliata, V. Gattei, P. Fazi, S.
Monfardini, A. Pinto
Leukemia 7 (suppl. 1), 36-41, 1993
102. MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE DOSE ARA-C (MEC): AN EFFECTIVE
REGIMEN FOR POOR RISK ACUTE MYELOID LEUKEMIA
A. Spadea, M.C. Petti, P. Fazi, M.L. Vegna, W. Arcese, G. Avvisati, M.A. Aloe Spiriti, R. Latagliata, G.
Meloni, A.M. Testi, S. Amadori, F. Mandelli
Leukemia 7 549-552, 1993
103. IN VIVO AND IN VITRO EFFECTS OF 5-AZA-2'-DEOXYCYTIDINE (DECITABINE) ON
CLONOGENIC CELLS FROM ACUTE MYELOID LEUKEMIA PATIENTS
V. Gattei, D. Aldinucci, M.C. Petti, A. Da Ponte, V. Zagonel, A. Pinto
Leukemia 7, (suppl. 1) 42-48, 1993
104. TRISOMY 14 IN HEMATOLOGIC DISEASES. AN OTHER NON-RANDOM ABNORMALITY
WITHIN PROLIFERATIVE DISORDERS
M. Mancini, M. Cedrone, M. Nanni, M.B. Rondinelli, M.C. Petti, M.R. De Cuia, G. Alimena
Cancer Genet Cytogenet 66, 39-42, 1993
105. EFFECT OF MAST CELL GROWTH FACTOR ON ARA-C MEDIATED ACUTE MYELOID
LEUKEMIA CELL KILLING
A. Tafuri, L. De Felice, M.G. Mascolo, T. Valentini, M.T. Petrucci, M.C. Petti
Stem Cells 11 (suppl 2), 88-92, 1993
106. WHAT IS THE BEST TREATMENT FOR ACUTE PROMYELOCYTIC LEUKEMIA?
G. Avvisati, M.C. Petti, F. Mandelli
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 10 / 23
Curriculum Vitae
Maria Concetta Petti
Leukemia and Lymphoma 11(suppl. 2), 29-35, 1993
107. LA ENTEROCOLITE NECROTIZZANTE NEI PAZIENTI NEUTROPENICI: RUOLO DELLA
CHIRURGIA
P. Chirletti, R. Caronna, P. Mingazzini, M.C. Petti, G. Prezioso, V. Stipa
Atti del IV Congresso Nazionale di Colonproctologia Roma 3-6 Marzo, 377-380; 1993
108. THERAPY OF ACUTE MYELOID LEUKEMIA: WHERE FROM NOW?
F. Mandelli, G. Avvisati, M.C. Petti
in "Haematology Trends '93", Lechner/Gadner (eds), p.1-18, Schattauer, 1993
109. LA TERAPIA DELLE LEUCEMIE ACUTE
F. Mandelli, G. Avvisati, G. Meloni, M.C. Petti
I Manuali delle Scuole, M.D. 13, Scuola Superiore di Oncologia e Scienze Biomediche-Scuola
Internazionale di Oncologia e Medicina Sperimentale 1993
110. ABSENCE OF REVERSE TRANSCRIPTON-POLYMERASE CHAIN REACTION
DETECTABLE RESIDUAL DISEASE IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA
IN LONG-TERM REMISSION
D. Diverio, P.P. Pandolfi, A. Biondi, G. Avvisati, M.C. Petti, F. Mandelli, P.G. Pellicci, F. Lococo
Blood 82, 3556-3559, 1993
111. ERYTHROPOIETIN TREATMENT OF IDIOPATHIC MYELOFIBROSIS
M.A. Aloe Spiriti, R. Latagliata, G. Avvisati, V. Battistel, E. Montefusco, A. Spadea, M.C. Petti
Haematologica 78, 371-373; 1993
112. CHEMIOTERAPIA D'INDUZIONE DELLE LEUCEMIE ACUTE MIELOIDI
G. Papa, A. Franchi, M.L. Vegna, M.C. Petti, F. Mandelli, R. Zittoun
In "Progressi in Ematologia Clinica", vol. XII "Leucemie acute '93", p. 95-102; 1993
113. QUAL'E' LA MIGLIORE TERAPIA PER LA LEUCEMIA ACUTA PROMIELOCITICA?
F. Mandelli, G. Avvisati, M. C. Petti
In "Progressi in Ematologia Clinica", vol. XII "Leucemie acute '93", p. 103-112; 1993
114. POLYCYTHAEMIA VERA AND CEREBRAL BLOOD FLOW: A PRELIMINARY STUDY WITH
TRANSCRANIAL DOPPLER G.
Fiermonte, M.A. Aloe Spiriti, R. Latagliata, M.C. Petti, P. Giacomini
J Internal Med 234, 599-602; 1993
115. SOUTHERN BLOT ANALYSIS OF ALL-1 REARRANGRMRNTS AT CHROMOSOME 11q23 IN
ACUTE LEUKEMIA
F. Lo Coco, F. Mandelli, M. Breccia, L. Annino, C. Guglielmi, M.C. Petti, A.M. Testi, G. Alimena, C. M.
Croce, E. Canaani, G Cimino
Cancer Research 53, 3800-3803; 1993
116. RECOMBINANT HUMAN ERYTHROPOIETIN IN THE TREATMENT OF MYELODYSPLASTIC
SYNDROMES. AN INTERIM REPORT
M.A. Aoe Spiriti, M.C. Petti, R. Latagliata, G. Avvisati, C. De Gregoris, S. Proia, P. Fazi, G. Jaalouk, M.
Mancini, A. Spadea, R. Villa, F. Mandelli
Haematologica 78: 123-126; 1993
117. LE LEUCEMIE ACUTE
M.C. Petti
In A. Fabbrini "Fondamenti di Medicina Interna" p.1119-1130; Pensiero Scientifico Editore, 1994
118. MIELODISPLASIE
M.C. Petti, M.A. Aloe-Spiriti
In A. Fabbrini "Fondamenti di Medicina Interna" p.1131-1138 Pensiero Scientifico Editore, 1994
119. AUTOLOGOUS OR ALLOGENEIC BONE MARROW TRANSPLANTATION COMPARED WITH
INTENSIVE CHEMOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA
R. Zittoun, F. Mandelli, R. Willemze, T De Witte, B. Labar, L. Resegotti, F. Leoni, E. Damasio, G.
Visani, G. Papa, F. Caronia, M. Hayat, P. Stryckmans, B. Rotoli, P. Leoni, M.E. Peetermans, M.
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 11 / 23
Curriculum Vitae
Maria Concetta Petti
Dardenne, M.L. Vegna, M.C. Petti, G. Solbu, S. Suciu
N Engl J Med 332, 217-223; 1995
120. IS AGGRESSIVE CHEMOTHERAPY THE BEST CHOISE FOR PATIENTS WITH ACUTE NON
LYNPHOCYTIC LEUKEMIA AFTER MYELODYSPLASTIC SYNDROMES?
R. Latagliata, M. A. Aloe Spiriti, G. Avvisati, C. De Gregoris, P. Fazi, A. Spadea, M. C. Petti
Leukemia Research 19, 213-217; 1995
121. MEC (MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE DOSE CYTARABINE):AN
EFFECTIVE INDUCTION REGIMEN FOR PREVIOUSLY UNTREATED ACUTE NONLYMPHOCYTIC LEUKEMIA
G. Visani, M.C. Petti, A. Cenacchi, S. Manfroi, P. Tosi, A. Spadea, R. Latagliata, S. Amadori, F.
Mandelli, S. Tura
Leukemia and Lymphoma 19, 447-451; 1995
122. INTERLEUKIN-3 PRIMING IN ACUTE MYELOID LEUKEMIA PATIENTS
A. Tafuri, L. De Felice, A. Godacre, S. Fenu, M.T. Petrucci, T. Valentino, G. Alimena, M.C. Petti, G.
Meloni, F. Mandelli
Br J Haematol 91, 234-244;1995
123. MULTIDRUG RESISTANCE EXPRESSION AND PROLIFERATION STUDIES IN POO RISK
ACUTE MYELOID EUKEMIA TREATED WITH THE FLAG (G-CSF PLUSFLUDARABINE AND
ARA-) REGIMEN
A. Tafuri,L. De Feli, M.T. Petrucci,M.G. Macolo,M.R. Ricciardi, C. Ciliberti, M.P. Marelli, M.C. Petti
Cytokines and Molecular Theraphy 1, 301-307; 1995
124. IN VITRO PURGING WITH BCR/ABL ANTISENSE OLIGODEOXINUCLEOTIDES DOES NOT
PREVENT HAEMATOLOGIC RECONSTITUTION AFTER AUTOLOGOUS BONE MARROW
TRANSPLANTATION
P. De Fabritiis, S. Amadori, M.C. Petti, M. Mancini, E. Montefusco, A. Picardi, T. Geiser, K. Campbell,
B. Calabretta, F. Mandelli
Leukemia 9, 662-664; 1995
125. A PHASE II STUDY OF VP16, INTERMEDIATE -DOSE ARA-C AND CARBOPLATIN (VAC) IN
ADVANCED ACUTE MYELOGENOUS LEUKEMIA AND BLASTIC CHRONIC MYELOGENOUS
LEUKEMIA
S. Amadori, A. Picardi, P. Fazi, A.M. Testi, M.C. Petti, E. Montefusco, F. Mandelli
Leukemia 10, 766-768; 1996
126. PROGNOSTIC FACTORS OF PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
ALLOGRAFTED IN FIRST COMPLETE REMISSION: AN ANALYSIS OF THE EORTC-GIMEMA
AML 8A TRIAL
S. Keating, S. Suciu, T: de Witte, F. Mandelli, R. Willemze, , L. Resegotti, G. Broccia, J. Taler,B. Labar,
E. Damasio, B. Bizzi, B. Rotoli, A. Vekhoff, P. Muus, , M.C. Petti, M. Dardenne, G. Solbu, M.L. Vegna,
R.A. Zittoun
Bone Marrow Transpl 17: 993-1001; 1996
127. GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ASSOCIATED WITH
INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA: A RANDOMIZED TRIAL BY
THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER LEUKEMIA
COOPERATIVE GROUPS
R. Zittoun, S. Suciuc, F. Mandelli, T. de Witte, J. Thaler, P. Stryckman, M. Hayat, M. Peetermans, M.
Cadiou, G. Solbu, M.C. Petti, R. Willemze
J Clin Oncol 14: 2150-2159; 1996
128. ERYTHOPOIETIN IN MYELODYSPLASTIC SYNDROMES: DURABLE RESPONSE IN A
YOUNG PATIENT
M.A. Aloe Spiriti, R. Latagliata, M.C. Petti
Haematologica 81: 381-382; 1996
129. AIDA (ALL-TRANS-RETINOIC ACID+IDARUBICIN) IN NEWLY DIAGNOSED ACUTE
PROMYELOCYTIC LEUKEMIA: A GRUPPO ITALIANO MALATTIE EMATOLOGICHE MALIGNE
DELL’ADULTO (GIMEMA) PILOT STUDY
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 12 / 23
Curriculum Vitae
Maria Concetta Petti
G. Avvisati, F. Lo Coco, D. Diverio, M. Falda, F. Ferrara, M. Lazzarino, D. Russo, M. C. Petti, F.
Mandelli
Blood 88: 1390-1398; 1996
130. OUTCOME OF PATIENTS WITH ACUTE MYELOID LEUKEMIA WHO FAILED TO RESPOND
TO A SINGLE COURSE OF FIRSTE LINE INDUCTION THERAPY: A GIMEMA STUDY OF 218
UNSELECTED PATIENTS
V. Liso, P. Iacopino, G. Avvisati, M.C. Petti, G. Broccia, M. Carotenuto, M. Falda, P. Fazi, M. Lazzarino,
P. Leoni, S. Mirto, G. Pucci, F. Nobile, A.M. Nosari, G. Specchia, R. Stasi, A. Tabilio, F. Mandelli
Leukemia 10: 1443-1452; 1996
131. LA LEUCEMIA ACUTA: DALLA BIOLOGIA ALLE TERAPIE
M.C. Petti
Ematologia, Collana Grandangolo, Accademia Nazionale di Medicina 1996
132. TERAPIA SOPRAMASSIMALE NELLA LEUCEMIA LINFOIDE CRONICA, NELLE SINDROMI
MIELODISPLASTICHE, NELLE MALATTIE AUTOIMMUNI
M. A. Aloe Spiriti, G. Meloni, M.C. Petti
In “Chemioterapia ad alte dosi nelle emolinfopatie maligne” vol. II: 24-54; 1996
133. TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES WITH LYMPHOBLASTOID
ALPHA INTERFERON
M.C. Petti, R. Latagliata, G. Avvisati, M. A. Aloe Spiriti, E. Montefusco, A. Spadea, F. Mandelli
Br J Haematol 95: 364-367; 1996
134. NEW STRATEGIES FOR THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
Petti, G. Avvisati, F. Mandelli
Corso della European School of Oncology, Bergamo, Settembre 1996
135. IL CANALE PARALLELO ROMANO (CPR). II. ORGANIZZAZIONE DIDATTICA E PRIMI
RISULTATI
Gruppo CPR
MEDIC 4: 78-83; 1996
136. PROBABILITY OF LONG-TERM DISEASE-FREE SURVIVAL FOR ACUTE MYELOID
LEUKEMIA PATIENTS AFTER FIRST RELAPSE: A SINGLE-CENTER EXPERIENCE
Vignetti, E. Orsini, M.C. Petti, M. L. Moletti, C. Andrizzi, R. M. Pinto, S. Amadori, G. Meloni
Annals of Oncology 7: 933-938; 1996
137. REVERSAL OF ENCEPHALOPATHY DURING TREATMENT WITH AMPHOTERICIN-B
G. Antonini, S. Morino, M. Fiorelli, P. Fazi, V. Ceschin, M.C. Petti
Journal of Neurological Sciences 144:212-213; 1996
138. ORAL GLUTAMINE IN THE PREVENTION OF CHEMOTHERAPY-INDUCED
GASTROINTESTINAL TOXICITY
Muscaritoli M, Micozzi A, Conversano L, Martino P, Petti MC, Cartoni C, Cascino A, Rossi Fanelli F
Eur J Cancer 33:319-320; 1997
139. LEUCEMIA ACUTA NON LINFOIDE
M. C. Petti
In L A Scuro “MEDICINA INTERNA FISOPATOLOGIA E CLINICA” UTET eds pp.485-510; 1997
140. ETOPOSIDE, INTERMEDIATE-DOSE CYTARABINE AND CARBOPLATIN (VAC): A
COMBINATION THERAPY FOR THE BLASTIC PHASE OF CHRONIC MYELOGENOUS
LEUKEMIA
E. Montefusco, M.C. Petti, G. Alimena. R. Latagliata, F. Celesti, S. Capria, S. Amadori, G. Avvisati, F.
Mandelli
Annals of Oncology 8:175-179; 1997
141. MOLECULAR REMISSION IN PML/RAR-POSITIVE ACUTE PROMYELO-CYTIC
LEUKEMIA BY COMBINED ALL-trans RETINOIC ACID AND IDARUBICIN (AIDA) THERAPY
Mandelli, D. Diverio, G. Avvisati, A Luciano, T Barbui, C Bernasconi, G Broccia, R Cerri, M Falda, G
fioritoni,, F Leoni, V Liso, MC Petti, F Rodeghiero, G Saglio, ML Vegna, G Visani, U Jehn, R Willemze,
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 13 / 23
Curriculum Vitae
Maria Concetta Petti
P Muus, PG Pellicci, A Biondi, F Lo Coco
Blood 90:1014-1021, 1997
142. AUTOLOGOUS BONE MARROW TRANSPLANTATION FOR ACUTE PROMYELOCYTIC
LEUKEMIA IN SECOND REMISSION: PROGNOSTIC RELEVANCE OF PRETRANSPLANT
MINIMAL RESIDUAL DISEASE ASSESSEMENT BY REVERSE-TRANSCRIPTION POLYMERASE
CHAIN REACTION OF THE PML/RAR FUSION GENE
G Meloni, D Diverio, M Vignetti, G. Avvisati, S Capria, MC Petti, F Mandelli
Blood 90:1321-1325; 1997
143. EUROPEAN COLLABORATION ON LOW-DOSE ASPIRIN IN POLYCYTHEMIA VERA
(ECLAP): A RANDOMIZED TRIAL
Landolfi R e Marchioli R (on behalf of the ECLAP investigators)
Seminars in Thrombosis and Haemostasis 23:437-448; 1997
144. THE ROLE OF ALL-TRANS-RETINOIC ACID (ATRA) TREATMENT IN NEWLY-DIAGNOSED
ACUTE PROMYELOCYTIC PATIENTS AGED > 60 YEARS
R Latagliata, G. Avvisati, F Lo Coco, MC Petti, D Diverio, A Spadea, P Fazi, C Torromeo, M Breccia, F
Malagnino, F Mandelli
Ann Oncol 8:1273-1275; 1997
145. POLYCYTHEMIA VERA TREATED WITH PIPOBROMAN AS SINGLE AGENT: LOW
INCIDENCE OF SECONDARY LEUKEMIA IN A COHORT OF PATIENTS OBSERVED DURING 20
YEARS (1971-1991)
MC Petti, A Spadea, G Avvisati, T Spadea, R Latagliata, E Montefusco, M Cosenza, F Malagnino
Leukemia 12:869-874; 1998
146. THE INFLUENCE OF HLA-MACHED SIBLING DONOR AVAILABILITY ON TREATMENT
OUTCOME FOR PATIENTS WITH AML: AN ANALYSIS OF THE AML 8A STUDY OF THE EORTC
LEUKEMIA COOPERATIVE GROUP AND GIMEMA
S Keating, T De Witte, S Sociu, R Willemze, M Hayat, B Labar, L Resegotti, PL Rossi Ferrini, F
Caroni, M Dardenne, G Solbu, MC Petti, ML Vegna, F Mandelli, R Zittoun
Br J Haematol 102:1344-1353;1998
147. CHEMIOTERAPIA DI SECONDA LINEA NEI PAZIENTI CON LEUCEMIA MIELOIDE ACUTA
RESISTENTI
G Avvisati, MC Petti
Progressi in Ematologia Clinica, vol 17, 119-128; 1998
148. BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDE IN VITRO PURGING AND
AUTOLOGOUS BONE MARROE TRANSPLANTATION FOR PATIENTS WITH CHRONIC
MYELOGENOUS LEUKEMIA IN ADVANCED PHASE
P de Fabritiis, MC Petti, E Montefusco, MS De Propris, R Sala, R Bellucci, M Mancini, A Lisci, F
Bonetto, T Geiser, B Calabretta, F Mandelli
Blood 91:3156-3162; 1998
149. SPLENECTOMY AND OF BLAST TRANSFORMATION IN MYELOFIBROSIS WITH MELOID
METAPLASIA. ITALIAN COOPERATIVE STUDY GROUP ON MYEOLOID METAPLASIA.
Barosi G, Ambrosetti A, Centra A, Falcone A, Finelli C, Foa P, Grossi A, Guarnone R, Rupoli S,
Luciano L, Petti MC, Pogliani E, Russo D, Ruggeri M, Quaglini S
Blood 15:3630-3616; 1998
150. FLUDARABINE, CYTARABINE, AND G-CSG (FLAG) FOR THE THE TREATMENT OF POOR
RISK ACUTE MYELOID LEUKEMIA
Montillo M, Mirto S, Petti MC, Latagliata R, Magrin S, Pinto A, Zagonel V, Mele G, Tedeschi A, Ferrara
F
Am J Hematol 58:105-109; 1998
151. THERAPY OF ACUTE MYELOID LEUKEMIA: TOWARDS A RISK -ADAPTED APPROACH
Mandelli F, Petti MC, Lo Coco F
Haematologica 83:1015-1023; 1998
152. NEW STRATEGIES FOR THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 14 / 23
Curriculum Vitae
Maria Concetta Petti
Mandelli F, Petti MC
In “Recent advances in Hematology” M Carotenuto Ed. pg11-21; 1998
153. EARLY EARLY DETECTION OF RELPASE BY PROSPECTIVE REVERSE TRANSCRIPTASEPOLYMERASE CHAIN RECTION ANALYSIS OF THE PML/RARALPHA FUSION GENE IN
PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA ENROLLED IN THE GIMEMA-AIEOP
MULTICENTER “AIDA” TRIAL
Diverio D, Rossi V, De Santis S, Pistilli A, Pane F, Saglio G, Martinelli G, Petti MC, Santoro A, Pelicci
PG, Mandelli F, Biondi A, Lo Coco FL
Blood 92:784-789; 1998
154. TRATTAMENTO DELLE SINDROMI MIELODISPLASTICHE CON ALFA-INTERFERON
LINFOBLASTOIDE: ESPERIENZA DELLA CATTEDRA DI EMATOLOGIA “LA SAPIENZA” DI ROMA
Breccia M, D’Elia GM, Luzi G, Latagliata R, Aloe Spiriti MA, Montefusco E, Spadea A, Petti MC
AH Cultura e Scienza 6:38-40; 1998
155. MOLECULAR ASSESMENT OF RESPONSE TO THERAPY IN ACUTE PROMYELOCYTIC
LEUKEMIA
Lo Coco F, Diverio D, Avvisati G, Petti MC, De Santis S, Pistilli A, Mandelli F
Haematologica 83 (suppl 1) 390-392; 1998
156. A SYSTEMATIC COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS COMPARING
IDARUBICIN WITH DAUNORUBICIN (OR OTHER ANTHRACYCLINES) AS INDUCTION
THERAPY FOR ACUTE MYELOID LEUKAEMIA
The AML Collaborative Group
Br J Haematol 103:100-109; 1998
157. PLASMA AMINO ACID CONCENTRATIONS IN PATIENTS WITH ACUTE LEUKEMIA
Muscaritoli M, Conversano L, Petti MC, Cascino A, Mecarocci S, Annichiarico MA, Fanelli FR
Nutrition 15:195-199; 1999
158. CORONARIC THROMBOTIC EVENTS IN ACUTE PROMYELOCYTIC LEUKEMIA DURING
ALL-TRANS RETINOIC ACID TREATMENT: A ROLE FOR ADHESION MOLECULS
OVEREXPRESSION?
Torromeo C, Latagliata R, Avvisati G, Petti MC, Mandelli F
Leukemia 13:312-313; 1999
159. THE ITALIAN CONSENSUS CONFERENCE ON DIAGNOSTIC CRITERIA FOR
MYELOFIBROSIS WITH MYELOID METAPLASIA
Barosi G, Ambrosetti A, Finelli C, Grossi A, Leoni P, Liberato NL, Petti M.C.,Pogliani E, Ricetti M,
Rupoli S, Visani G, Tura S
Br J Haematol 104:730-737; 1999
160. LEUCEMIA MIELOIDE ACUTA
Pinto A, Petti MC, Ferrara F, Babare R, Gattei V, Zagonel V
Argomenti di Oncologia 20:59-65;1999
161. THROMBOPOIETIN AND INTERLEUKIN 11 HAVE DIFFERENT MODULATORY EFFECTS
ON CELL CYCLE AND PROGRAMMED CELL DEATH IN PRIMARY ACUTE MYELOID LEUKEMIA
CELLS
Tafuri A, Lemoli RM, Petrucci MT, Ricciardi MR, Fogli M, Bonsi L, Ariola C, Strippoli P, Gregorj C, Petti
MC, Tura S, Mandelli F, Bagnara GP
Hexperimental Hematology 27: 1255-1263; 1999
162. THERAPY OF MOLECULAR RELAPSE IN ACUTE PROMYELOCITIC LEUKEMIA
Lo Coco F, Diverio D, Avvisati G, Petti MC, Meloni G, Pogliani EM, Biondi A, Rossi G, Carlo Stella C,
Selleri C, Martino B, Specchia G, Mandelli F
Blood 94: 2225-2229, 1999
163. ACUTE MYELOID LEUKEMIA IN THE ELDERLY: ‘PER ASPERA AD ASTRA?’
Latagliata R, Petti MC, Mandelli F
Leukemia Research 23:603-613; 1999
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 15 / 23
Curriculum Vitae
Maria Concetta Petti
164. A CASE CONTROL STUDY OF THE EFFECTS OF HYDROXYUREA ON CIRCULATING
CORTISOL LEVELS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA AND CHRONIC
MYELOPROLIFERATIVE DISORDERS
Navarra P, Aloe Siriti MA, Boccarini F, Montefusco E, Latagliata R, Preziosi P, Petti MC
Pharmacol Res 42: 389-392; 2000
165. DEFINITION OF RELAPSE RISK AND ROLE OF NONANTHRACYCLINE DRUGS FOR
CONSOLIDATION IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: A JOINT STUDY
OF THE PETHEMA AND GIMEMA COOPERATIVE GROUPS
Sanz MA, Lo Coco F, Martin G, Avvisati G, Rayon C, Barbui T, Diaz-Mediavilla J, Fioritoni G, Gonzales
JD, Liso V, Esteve J, Ferrara F, Bolufer P, Bernasconi C, Gonzales M, Rodeghiero F, Colomer D, Petti
MC, Ribera J, Mandelli F
Blood 96: 1247-1253; 2000
166. MOLECULAR AND CYTOGENETIC REMISSION IN A CASE OF SUBTYPE M4E ACUTE
MYELOGENOUS LEUKEMIA WITH MINIMAL CHEMOTHERAPY;HIGH SENSITIVITY OR
SPONTANEOUS REMISSION?
Martelli MP, Latagliata R, Spadea A, Avvisati G, Mancini M, Luzi G, Petti MC
Eur J Haematol 65:203-206; 2000
167. MOLECOLAR REMISSION FOLLOWING HIGH-DOSE HYDROXYUREA AND FLUDARABINE
PLUS CYTARABINE IN A PATIENT WITH SIMULTANEOUS ACUTE MYELOID LEUKEMIA AND
LOW -GRADE LYMPHOMA
Montefusco E. Fazi F, Cordone I, Ariola C, Nanni M, Spadea A, Aloe Spiriti MA, Fenu S, Mandelli F,
Petti MC
Leukemia and Lymphoma 40:671-674; 2001
168. GRANULOCYTIC SARCOMA WITH BREAST AND SKIN PRESENTATION: A REPORT OF A
CASE SUCCESSFULLY TREATED BY LOCAL RADIATION AND SYSTEMIC CHEMOTHERAPY
Breccia M, Petti MC, Fraternali-Orcioni G, Monarca B, Latagliata R, D’Elia GM, Mandelli F, Pileri SA
ActaHaematol 104: 34-37; 2000
169. ACUTE MYELOBLASTIC LEUKEMIA SECONDARY TO MYELODISPLASIA (MDS-AML): A
COMPARISON OF REMISSION INDUCTION WITH THREE DRUGS VERSUS STANDARD TWODRUGS INDUCTION
Latagliata R, Breccia M, Pulsoni A, Aloe Spiriti MA, Spadea A, Montefusco E, Luzi G, Betrò P and Petti
MC
Leukemia and Lymphoma 35: 539-541; 2000
170. ACUTE MYELOID LEUKEMIA IN PATIENTS PREVIOUSLY DIAGNOSED WITH BREAST
CANCER
Pagano L, Pulsoni A, Mele L, Tosti ME, Cerri R, Visani G, Melillo L, Candoni A, Clavio M, Nosari A,
Petti MC, Martino B, Mele A, Levis A, Allione B, Almici C, Equitani F, Leone G, Mandelli F
Ann Oncol 12: 203-207; 2001
171. NEUTROPENIC ENTEROCOLITIS IN PATIENTS WITH ACUTE LEUKEMIA: PROGNOSTIC
SIGNIFICANCE OF BOWEL WALL THICKENING DETECTED BY ULTRASONOGRAPHY
Cartoni C, Dragoni F, Micozzi A, Pescarmona E, Mecarocci S, Chirletti P, Petti MC, Meloni G, Mandelli
F
J Clin Oncol 19:756-761; 2001
172. PHENOTIPIC AND FUNCTIONAL CHARACTERIZATION OF THE HOST IMMUNE
COMPARTMENT OF CHRONIC MYELOID LEUKEMIA PATIENTS IN COMPLETE
HAEMATOLOGICAL REMISSION
Guarini A, Breccia M, Montefusco E, Petti MC, Zepparoni A, Vitale A, Foà R
Br J Haematol 113:136-142; 2001
173. THE PROGNOSTIC VALUE OF CYTOGENETICS IS REINFORCED BY THE KIND OF
INDUCTION/CONSOLIDATION THERAPY IN INFLUENCING THE OUTCOME OF ACUTE
MYELOID LEUKEMIA – ANALYSIS OF 848 PATIENTS
Visani G, Bernasconi P, , Boni M, Castodi GL, Ciolli S, Clavio M, Cox MC, Cuneo A, Del Poeta G, Dini
D, Falzetti D, Fanin R, Gobbi M, Isidori A, Leoni F, Liso V, Malagola M, Martinelli G, Mecucci C,
Piccaluga PP, Petti MC, Rondelli R, Russo D, Sessarego M, Specchia G, Testoni N, Torelli G, Mandelli
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 16 / 23
Curriculum Vitae
Maria Concetta Petti
F, Tura S
Leukemia 15:903-909; 2001
174. PROLONGED MOLECULAR REMISSION IN ADVANCED ACUTE PROMYELOCYTIC
LEUKEMIA AFTER TREATMENT WITH GEMTUZUMAB OZOGAMICIN (MYLOTARG CMA-676)
Petti MC, Pinazzi MB, Diverio D, Romano A, Petrucci MT, De Santis S, Meloni G, Tafuri A, Mandelli F,
Lo Coco F
Br J Haematol 115: 63-65; 2001
175. SPONTANOUS REMISSION IN ADULT PATIENTS WITH DE NOVO MYELODYSPLASTIC
SYNDROME: A POSSIBLE EVENT
Petti MC, Latagliata R, Breccia M, Alimena G, Spadea A, D’Andrea M, Mancini M, Aloe Spiriti MA,
Mandelli F
Haematologica 86: 1277-1280; 2001
176. INTRAVENTRICULAR THROMBOSIS DURING ALL-TRANS RETINOIC ACID TREATMENT IN
ACUTE PROMYELOCYTIC LEUKEMIA
Torromeo C, Latagliata R, Avvisati G, Petti MC, Mandelli F
Leukemia 15:1311-1313; 2001
177. THERAPY RELATED MYELODYSPLASTIC SYNDROME - ACUTE MYELOGENOUS
LEUKEMIA IN PATIENTS TREATED FOR ACUTE PROMYELOCYTIC LEUKEMIA:AN EMERGING
PROBLEM
Latagliata R, Petti MC, Fenu S, Mancini M, Spiriti MA, Breccia M, Brunetti GA, Avvisati G, Lococo F,
Mandelli F
Blood 99: 822-824; 2002
178. MELPHALAN TREATMENT IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID
METAPLASIA
Petti MC, Latagliata R, Spadea T, Spadea A, Montefusco E, Aloe Spiriti MA, Avvisati G, Breccia M,
Pescarmona E, Mandelli F
Br J Haematol 116:576-581; 2002
179. MALATTIE MIELOPROLIFERATIVE
Avvisati G, Petti MC
Collana “I Manuali”, serie M.D. Accademia Nazionale di Medicina; 2002
180. CUTANEOUS PLEOMORPHIC t-CELL LYMPHOMA COEXISTING WITH
MYELODYSPLASTIC SYNDROME TRASFORMING INTO ACUTE MYELOID LEUKEMIA:
SUCCESSFUL TREATMENT WITH FLUDARABINE-CONTAINING REGIMEN
Breccia M, Petti MC, D’Elia GM, D’Andrea M, Carmosino I, Alimena G.
Eur J Haematol 68:1-3, 2002
181. EAR INVOLVEMENT IN ACUTE PROMYELOCYTIC LEUKEMIA AT RELAPSE: A DISEASEASSOCIATED “SANCTUARY”?
Breccia M, Petti MC, Testi AM, Specchia G, Ferrara F, Diverio D, Romano AM, Guerrisi V, Greco A,
Fiorella ML, De Vincentiis M, Mandelli F, Lo Coco F
Leukemia 16:1127-1130; 2002
182. COMPLETE REMISSION THROUGH BLAST CELL DIFFERENTIATION IN PLZF/RARALFAPOSITIVE ACUTE PROMYELOCYTIC LEUKEMIA: IN VITRO AND IN VIVO STUDIES.
Petti MC, Fazi F, Gentile M, Diverio D, De Fabritiis P, De Propris MS, Fiorini R, Spiriti MA, Padula F,
Pelicci PG, Nervi C, Lo Coco F.
Blood 100:1065-1067; 2002
183. DIABETES INSIPIDUS AS FIRST MANIFESTATION OF ACUTE MYELOID LEUKEMIA WITH
EVI-1 POSITIVE, 3q21q26 SYNDROME AND T CELL-LINE ANTIGEN EXPRESSION: WHAT IS
THE EVI-1 ROLE?
Breccia M, Petti MC, Ottaviani E, Mancini M, D’Elia GM, Mecarocci S, Alimena G.
Br J Haematol 118:438-441; 2002
184. ACUTE MEGAKARIOBLASTIC LEUKEMIA: EXPERIENCE IF GIMEMA TRIALS
Pagano L, Pulsoni A, Vignetti M, Mele L, Fianchi L, Petti MC, Mirto S, Falcucci P, Fazi P, Broccia G,
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 17 / 23
Curriculum Vitae
Maria Concetta Petti
Specchia G, Di Raimondo F, Pacilli L, Leoni P, Ladogana S, Gallo E, Venditti A, Avanzi G, Camera A,
Liso V, Leone G, Mandelli F; for the GIMEMA
Leukemia 16:1622-1626; 2002
185. INDUCTION THERAPY WITH IDARUBICIN ALONE SIGNIFICANTLY INFLUENCES
EVENT.FREE SURVIVAL DURATION IN PATIENTS WITH NEWLY DIAGNOSED
HYPERGRANULAR ACUTE PROMYELOCYTIC LEUKEMIA: FINAL RESULTS OF THE GIMEMA
RANDOMIZED STUDY LAP 0389 WITH 7 YEARS OF MINIMAL FOLLOW-UP
Avvisati G, Petti MC, Lo Coco F, Vegna ML, Amadori S, Baccarani M, Cantore N, Di Bona E, Ferrara
F, Fioritoni G, Gallo E, Invernizzi R, Lazzarino M, Liso V, Mariani G, Ricciuti F, Selleri C, Sica S, Veneri
D, Mandelli F
Blood 100:3141-3146; 2002
186. ALTERATIONS OF THE FLT3 GENE IN ACUTE PROMYELOCYTIC LEUKEMIA:
ASSOCIATION WITH DIAGNOSTIC CHARACTERISTICS AND ANALYSIS OF CLINICAL
OUTCOME IN PATIENTS TREATED WITH THE ITALIAN AIDA PROTOCOL
Noguera NI, Breccia M, Divona M, Diverio D, Costa V, De Santis S, Avvisati G, Pinazzi MB, Petti MC,
Mandelli F, Lo Coco F.
Leukemia 16:2185-2189; 2002
187. CONSERVATIVE TREATMENT FOR PATIENTS OVER 80MYEARS WITH ACUTE
MYELOGENOUS LEUKEMIA
Latagliata R, Alimena G, Carmosino I, Breccia M, Borza PA, Bongarzoni V, Copia C, Spadea A,
Pinazzi B, Frattarelli N, Ferrara F, Petti MC, Mandelli F
Am J Hematol 71:256-259; 2002
188. L’ANZIANO AFFETTO DA LEUCEMIA ACUTA
MC Petti
In “Oncologia Geriatrica 1 – Una realtà clinica emergente” Pensiero Scientifico Eds p.119-138; 2002
189. EARLY DETECTION OF MENINGEAL LOCALIZATION IN ACUTE PROMYELOCYTIC
LEUKAEMIA PATIENTS WITH HIGH PRESENTING LEUCOCYTE COUNT
Breccia M, Carmosini I, Diverio D, De Santis S, De Propris MS, Romano A, Petti MC, Mandelli F, Lo
Coco F
Br J Haematol 120:266-270; 2003
190. TREATMENT OF ELDERLY PATIENTS (> or = 60 YEARS) WITH NEWLY DIAGNOSED
ACUTE PROMYELOCYTIC LEUKEMIA. RESULTSOF THE ITALIAN MULTICENTER GROUP
GIMEMA WITH ATRA AND IDARUBICIN (AIDA) PROTOCOLS
Mandelli F, Latagliata R, Avvisati G, Fazi P, Rodeghiero F, Leoni F, Gobbi M, Nobile F, Gallo E, Fanin
R, Amadori S, Vignetti M, Fioritoni G, Ferrara F, Peta A, Giustolisi R, Broccia G, Petti MC, Lococo F.
Italian GIMEMA Cooperative Group
Leukemia 17:1085-1090; 2003
191. L’IMPIEGO DELL’ERITROPOIETINA NELL’ANZIANO
Petti MC
In “La patologia ematologica dell’anziano” Pensiero Scientifico Eds p.77-83; 2003
192. HIGH DOSE HYDROXYUREA IN THE TREATMENT OF POOR RISK MYELOID LEUKEMIAS
Petti MC, Tafuri A, Latagliata R, Aloe Spiriti MA, Montefusco E, Mancini M, Meloni G, Petrucci MT,
Spadea A, Redi R, Alimena G, Mandelli F
Ann Hematol 82:476-480; 2003
193. CLINICO-BIOLOGICAL FEATURES AND OUTCOME OF ACUTE PROMYELOCYTIC
LEUKEMIA PATIENTS WITH PERSISTENT POLYMERASE CHAIN REACTION-DETECTABLE
DISEASE AFTER AIDA FRONT-LINE INDUCTION AND CONSOLIDATION THERAPY
Breccia m, Diverio D, Noguerra NI, Visani G, Santoro A, Locatelli F, Damiani D, Marmont F, Vignetti M,
Petti MC, Lo Coco F.
Haematologica 89:29-33; 2004
194. SURVIVAL OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA
Pulsoni A, Pagano L, Latagliata R, Casini M, Cerri R, Crugnola M, De Paoli L, Di Bona E, Invernizzi R,
Marmont F, Petti MC, Rigolin G, Ronco F, Spadano A, Tosti ME, Visani G, Mele A, Mandelli F.
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 18 / 23
Curriculum Vitae
Maria Concetta Petti
Haematologica 89:296-302; 2004
195. ACUTE MYELOID LEUKEMIA SECONDARY TO A MYELODYSPLASTIC SYNDROME WITH
t(3;3) (q21;q29) IN AN hiv PATIENT TREATED WITH HIGH CHEMOTHERAPY AND HIGHLY
ACTIVE ANTIRETROVIRAL THERAPY
Breccia M, Gentile G, Martino P, Petti MC, Mancini M, Alimena G
Acta Haematol 111:160-162; 2004
196. ARSENIC TRIOXIDE IN THE TREATMENT OF ADVANCED ACUTE PROMYELOCYTIC
LEUKEMIA
Carmosino I, Latagliata R, Breccia M, Finolezzi E, Lo Coco F, Petti MC
Haematologica 89:615-617; 2004
197. APOPTOSIS SUSCEPTIBILITY AND CELL-CYCLE DISTRIBUTION IN CELLS FROM
MYELODYSPLASTIC SYNDROME PATIENTS: MODULATORY IN VITRO EFFECTS OF G-CSF
AND INTERFERON-ALPHA
Ricciardi MR, Petrucci MT, Gregorj C, Martini V, Levi A, De Cuia MR, Latagliata R, Petti MC, Mandelli
F, Foà R, Tafuri A.
Leuk Lymphoma 45:1437-1443; 2004
198. CLINICO-PATHOLOGICAL CHARACTERISTICS OF MYELOID SARCOMA AT DIAGNOSIS
AND DURING FOLLOW-UP: REPORT OF 12 CASES FROM A SINGLE INSTITUTION
Breccia M, Mandelli F, Petti MC, D’Andrea M, Pescarmona E, Pileri SA, Carmosino I, Russo E, De
Fabritiis P, Alimena G.
Leuk Res 28:1165-1169; 2004
199. ZOLENDRONIC ACID-ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA
Ferretti G, Petti MC, Carlini P, Zeuli M, Picardi A, Meloni G, Bria E, Papaldo P, Fabi A, Cognetti F.
Ann Oncol 15:1847-1848; 2004
200. COMPLEX VARIANT PHILADELFIA TRANSLOCATION INVOVLVING THE SHORT ARM OF
CHROMOSOME 9 IN A CASE OF CHRONIC MYELOID LEUKEMIA
Cianciulli AM, Marzano R, Merola R, Orlandi G, Petti MC, Guadagni F, Pisani F.
Haematologica 89:ECR37 2004
201. IMPACT OF NEW DOSING REGIMEN OF EPOETIN ALFA ON QUALITY OF LIFE AND
ANEMIA IN PATIENTS WITH LOW RISK MYELODYSPLASTIC SYNDROME
Aloe Spiriti MA, Latagliata R, Discola P, Cortelezzi A, Francescani M, Ferrari D, Volpe E, Clavio M,
Grossi A, Tambone Reyes M, Musto P, Mitra ME, Azzarà A, Panini D, D’Arena D, Spadano A, Balleari
E, Pecorari P, Capochiani E, De Biasi E, Perego D, Monarca B, Pisani F, Scaramella G, Petti MC.
Ann Hematol 84:167-176; 2005
202. BAVC REGIMEN AND AUTOLOGOUS BONE MARROW TRANSPLANTATION FOR APL
PTINTS IN SECOND MOLECULAR REMISSION: UPDATED RESULTS.
Capria S, Latagliata R, Avvisati G, Breccia M, Cimino G, Diveerio D, Petti MC, Meloni G.
Bone marrow transplant. 36:83-84; 2005
203. MULTIPLE RELAPSES AND EXTRAMEDULLARY LOCALIZATION WITH SCALP AND
BREAST INVOLVEMENT IN A CASE OF ACUTE PROMYELOCYTIC LEUKEMIA
Ammatuna E, Borza PA, Iori AP, Petti MC, Pescarmona E, Diverio D, Lo Coco F
Leukemia 19:479-480; 2005
204. NK/T-CELL LYMPHOMAS “NASAL TYPE”: AN ITALIAN MULTICENTRIC RETROSPECTIVE
SURVEY
Pagano L, Gallamini A, Trape G, Fianchi L, Mattedi D, Todescini G, Spadea A, Cinieri S, Iannitto E,
Martelli M, Nosari A, Bona ED, Tosti ME, Petti MC, Falcucci P, Montanaro M, Pulsioni A, Larocca LM,
Leone G Intergruppo Italiano Linfomi
Ann Oncol 17:794-800; 2006
205. DIFFUSE LARGE B-CELL LYMPHOMA INVOLVING THE BREAST. A REPORT OF FOUR
CASES
Pisani f, Romano A, Anticoli-Borza P, Marino M, Micheli A, Botti C, Petti MC
J Exp Clin Cancer Res 25:277-281; 2006
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 19 / 23
Curriculum Vitae
Maria Concetta Petti
206. ACUTE MYELOGENOUS LEUKEMIA IN ELDERLY PATIENTS NOT ELIGIBLE FOR
INTENSIVE CHEMOTHERAPY: THE DARK SIDE OF THE MOON.
Latagliata R. Bongarzoni V., Carmosino I. Mengarelli A., Breccia M., Borza PA, D’Andrea M, D’Elia
GM, Mecarocci S, Morano SG, Petti MC, Mandelli F, Alimena G
Ann Oncol 17:281-285; 2006
207. SEQUENTIAL VALPROIC ACID/ALL-TRANS RETINOIC TREATMENT REPROGRAMS
DIFFERENTIATION IN REFRACTORY AND HIGH RISK ACUTE MYELOID LEUKEMIA
Cimino G, Lo Coco F, Fenu S, Travaglini L, Finolezzi E, Mancini M, Nanni M, Careddu A, Fazi F,
Padula F, Fiorini R, Aloe Spiriti MA, Petti MC, Venditti A, Amadori S, Mandelli F, Pelicci PG, Nervi C
Cancer Res 66:8903-8911; 2006
208. DOPPLER FLOWMETRY OF SPLENIC VESSELS IN LYMPHOPROLIFERATIVE
DISORDERS: PRELIMINARY RESULTS.
Solvetti F, Spadea A, Brigida R, Pisani F, Petti MC
J Exp Clin Cancer Res 25:453-455; 2006
209. OCCURRENCE OF THROMBOTIC EVENTS IN ACUTE PROMYELOCYTIC LEUKEMIA
CORRELATES WITH CONSISTENT IMMUNOPHENOTYPIC AND MOLECULAR FEATURES
Breccia M, Avvisati G, Latagliata R, Carmosino I, Guarini A, De Propris MS, Gentilini F, Petti MC,
Cimino G, Mandelli F, Lo Coco F
Leukemia 21:79-83; 2007
210. LATE RELAPSES IN ACUTE PROMYELOCYTIC LEUKAEMIA
Latagliata R, Carmosino I, Breccia M, Minni A, Testi AM, Iorio N, Lo Coco F, Avvisati G, Petti MC,
Mandelli F, Cimino F
Acta Haematol 117:106-108; 2007
211. CLINICAL AND BIOLOGICAL FEATURES OF ACUTE PROMYELOCYTIC LEUKEMIA
PATIENTS DEVELOPING RETINOIC ACID SYNDROME DURING INDUCTION TREATMENT
WITH ALL-TRANS RETINOIC ACID AND IDARUBICIN
Breccia M, Latagliata R, Carmosino I, Cannella L, Diverio D, Guarini A, De Propris MS, Petti MC, ,
Avvisati G, Cimino G, Mandelli F, Lo Coco F
Haematologica 93:1918-20; 2008
212. FOLLICULAR DENDRITIC CELL SARCOMA OF THE NECK: REPORT OF A CASE TREATED
BY SURGICAL EXCISION AND COP PLUS(PEG)-LIPOSOMAL DOXORUBICIN
Pisani F, Marino M, Sentinelli S, Petti MC
J Exp Clin Cancer Res 2:27-33; 2008
213. DAUNORUBICIN VERSUS MITOXANTRONE VERSUS IDARUBICIN AS INDUCTION AND
CONSOLIDATION CHEMOTHERAPY FOR ADULTS WITH ACUTE MYELOID LEUKEMIA: THE
EORTC AND GIMEMA GROUPS STUDY AML-10. Mandelli F, Vignetti M, Suciu S, Stasi R, Petti MC,
Meloni G, Muus P, Marmont F, Marie JP, Labar B, Thomas X, Di Raimondo F, Willemze R, Liso V,
Ferrara F, Baila L, Fazi P, Zittoun R, Amadori S, de Witte T.“ J Clin Oncol. 2009 Nov 10;27(32):5397403. Epub 2009 Oct 13.PMID: 19826132
214. CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, METHOTREXATE, BLEOMICIN
AND PREDNISONE PLUS RITUXIMAB IN UNTREATED YOUNG PATIENTS WITH LOW-RISK
(AGE-ADJUSTED INTERNATIONAL PROGNOSTIC INDEX 0-1) DIFFUSE LARGE B-CELL
LYMPHOMA. Derenzini E, Stefoni V, Pellegrini C, Fina MP, Broccoli A, Venturini F, Gandolfi L, Pileri
SA, Martelli M, Petti MC, Perrotti A, De Renzo A, Zaja F, Baccarani M, Zinzani PL. Leuk Lymphoma.
2009 Nov;50(11):1824-9.PMID: 19814687 in process
215. DECISIONAL FLOW WITH A SCORING SYSTEM TO START PLATELET-LOWERING
TREATMENT IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA: LONG-TERM RESULTS.
Latagliata R, Rago A, Spadea A, Santoro C, Carmosino I, Breccia M, Napoleone L, Fama A, Biondo F,
Volpicelli P, Vozella F, Stefanizzi C, Petti MC, Alimena G, Mazzucconi MG. “Int J Hematol. 2009
Nov;90(4):486-91. Epub 2009 Aug 22.PMID: 19701677 in process
216. VALPROIC ACID AT THERAPEUTIC PLASMA LEVELS MAY INCREASE 5-AZACYTIDINE
EFFICACY IN HIGHER RISK MYELODYSPLASTIC SYNDROMES. Voso MT, Santini V, Finelli C,
Musto P, Pogliani E, Angelucci E, Fioritoni G, Alimena G, Maurillo L, Cortelezzi A, Buccisano F, Gobbi
M, Borin L, Di Tucci A, Zini G, Petti MC, Martinelli G, Fabiani E, Fazi P, Vignetti M, Piciocchi A, Liso V,
Amadori S, Leone G. Clin Cancer Res. 2009 Aug 1;15(15):5002-7. Epub 2009 Jul 28.PMID:
19638460
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 20 / 23
Curriculum Vitae
Maria Concetta Petti
217. THE CONTROVERSIAL ROLE OF LAMIVUDINE PROPHYLAXIS IN OCCULT HBV
CARRIERS TREATED WITH CHEMO-IMMUNE THERAPY.D'Andrea M, Nosotti L, Pimpinelli F,
Dessanti ML, Paviglianiti A, Miglioresi L, Morrone A, Petti MC. Dig Liver Dis. 2009 Nov;41(11):839-40.
Epub 2009 May 21. No abstract available. PMID: 9464241
218. “REDUCTION OF SERUM IGF-I LEVELS IN PATIENTS AFFECTED WITH MONOCLONAL
GAMMOPATHIES OF UNDETERMINED SIGNIFICANCE OR MULTIPLE MYELOMA.
COMPARISON WITH BFGF, VEGF AND K-RAS GENE MUTATION”.Greco C, Vitelli G, Vercillo G,
Vona R, Giannarelli D, Sperduti I, Pisani F, Capoluongo E, Petti MC, Ameglio F. J Exp Clin Cancer
Res. 2009 Mar 10;28:35.
219. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by riskadapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA
Group. Lo-Coco F, Avvisati G, Vignetti M, Breccia M, Gallo E, Rambaldi A, Paoloni F, Fioritoni G,
Ferrara F, Specchia G, Cimino G, Diverio D, Borlenghi E, Martinelli G, Di Raimondo F, Di Bona E, Fazi
P, Peta A, Bosi A, Carella AM, Fabbiano F, Pogliani EM, Petti MC, Amadori S, Mandelli F; Italian
GIMEMA Cooperative Group. Blood. 2010 Oct 28;116(17):3171-9.
220. Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral
blood progenitor cell mobilization. Romeo A, Chierichini A, Spagnoli A, Vittori M, Vacca M, Gozzer M,
Spadea A, Anaclerico B, Dessanti ML, D'Andrea M, Toglia G, Annino L, Petti MC, Mengarelli A, Arcese
W. Transfusion. 2010 Jun 10.
221. Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously
untreated high-risk elderly diffuse large B-cell lymphoma patients. Zinzani PL, Rossi G, Franceschetti
S, Botto B, Di Rocco A, Cabras MG, Petti MC, Stefoni V, Broccoli A, Fanti S, Pellegrini C, Montini GC,
Gandolfi L, Derenzini E, Argnani L, Fina M, Tucci A, Bottelli C, Pileri S, Baccarani M. Clin Cancer Res.
2010 Aug 1;16(15):3998-4004.
222. Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation
chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML10. Mandelli F, Vignetti M, Suciu S, Stasi R, Petti MC, Meloni G, Muus P, Marmont F, Marie JP, Labar
B, Thomas X, Di Raimondo F, Willemze R, Liso V, Ferrara F, Baila L, Fazi P, Zittoun R, Amadori S, de
Witte T. J Clin Oncol. 2009 Nov 10;27(32):5397-403. Epub 2009 Oct 13. Erratum in: J Clin Oncol.
2010 Mar 10;28(8):1438.
223. Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus
rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1)
diffuse large B-cell lymphoma. Derenzini E, Stefoni V, Pellegrini C, Fina MP, Broccoli A, Venturini F,
Gandolfi L, Pileri SA, Martelli M, Petti MC, Perrotti A, De Renzo A, Zaja F, Baccarani M, Zinzani PL.
Leuk Lymphoma. 2009 Nov;50(11):1824-9.
224. Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential
thrombocythemia: long-term results. Latagliata R, Rago A, Spadea A, Santoro C, Carmosino I,
Breccia M, Napoleone L, Fama A, Biondo F, Volpicelli P, Vozella F, Stefanizzi C, Petti MC, Alimena G,
Mazzucconi MG. Int J Hematol. 2009 Nov;90(4):486-91.
225. Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk
myelodysplastic syndromes. Voso MT, Santini V, Finelli C, Musto P, Pogliani E, Angelucci E, Fioritoni
G, Alimena G, Maurillo L, Cortelezzi A, Buccisano F, Gobbi M, Borin L, Di Tucci A, Zini G, Petti MC,
Martinelli G, Fabiani E, Fazi P, Vignetti M, Piciocchi A, Liso V, Amadori S, Leone G. Clin Cancer Res.
2009 Aug 1;15(15):5002-7.
226. The controversial role of lamivudine prophylaxis in occult HBV carriers treated with chemoimmune therapy. D'Andrea M, Nosotti L, Pimpinelli F, Dessanti ML, Paviglianiti A, Miglioresi L, Morrone
A, Petti MC. Dig Liver Dis. 2009 Nov;41(11):839-40.
227. Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus
dexamethasone as induction therapy before, and consolidation therapy after, double autologous stemcell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study. Cavo M,
Tacchetti P, Patriarca F, Petrucci MT, Pantani L, Galli M, Di Raimondo F, Crippa C, Zamagni E,
Palumbo A, Offidani M, Corradini P, Narni F, Spadano A, Pescosta N, Deliliers GL, Ledda A, Cellini C,
Caravita T, Tosi P, Baccarani M; GIMEMA Italian Myeloma Network. Lancet. 2010 Dec
18;376(9758):2075-85.
228. Long-term seventh molecular remission in acute promyelocytic leukaemia. Cicconi L, Romano A,
Ramadan SM, Divona M, Petti MC, Lo-Coco F. Ann Hematol. 2011 Nov;90(11):1369-70. 2011 Feb 19.
229. FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by 90Yttrium ibritumomab
tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9
cases. Pisani F, Maini CL, Sciuto R, Dessanti L, D'Andrea M, Assisi D, Petti MC. J Exp Clin Cancer
Res. 2011 Feb 8;30:16.
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 21 / 23
Curriculum Vitae
Maria Concetta Petti
230. AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results
and role of maintenance. Avvisati G, Lo-Coco F, Paoloni FP, Petti MC, Diverio D, Vignetti M, Latagliata
R, Specchia G, Baccarani M, Di Bona E, Fioritoni G, Marmont F, Rambaldi A, Di Raimondo F, Kropp
MG, Pizzolo G, Pogliani EM, Rossi G, Cantore N, Nobile F, Gabbas A, Ferrara F, Fazi P, Amadori S,
Mandelli F; GIMEMA, AIEOP, and EORTC Cooperative Groups. Blood. 2011 May 5;117(18):4716-25.
Epub 2011 Mar 8.
231. GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia.
Long-term results and prognostic factors. Latagliata R, Breccia M, Fazi P, Vignetti M, Di Raimondo F,
Sborgia M, Vincelli D, Candoni A, Salvi F, Rupoli S, Martinelli G, Kropp MG, Tonso A, Venditti A, Melillo
L, Cimino G, Petti MC, Avvisati G, Lo-Coco F, Mandelli F; GIMEMA Acute Leukaemia Working Party.
Br J Haematol. 2011 Sep;154(5):564-8. doi: 10.1111/j.1365-2141.2011.08593.x. 2011 Jul 14.
232. Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's
lymphoma patients treated with immunochemotherapy. Nosotti L, D'Andrea M, Pitidis A, Pimpinelli F,
Dessanti ML, Pisani F, Vignally P, Petti MC. Scand J Infect Dis. 2011 Sep 12.
233. Trigeminal neuralgia as unusual isolated symptom of fungal paranasal sinusitis in patients with
haematological malignancies. Maschio M, Mengarelli A, Girmenia C, Vidiri A, Kayal R, Gallo MT,
Prignano G, Dessanti ML, D'Andrea M, Petti MC. Neurol Sci. 2011 Oct 7.
234. The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant
cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell
transplantation: A study from the Rome Transplant Network. Marchesi F, Giannotti F, Avvisati G, Petti
MC, Pimpinelli F, Paba P, Dessanti ML, Cerretti R, Tirindelli MC, Picardi A, D'Andrea M, Spadea A,
Ensoli F, Perno CF, Mengarelli A, Arcese W. Am J Hematol. 2011 Oct 12.
235. Increased body mass index correlates with higher risk of disease relapse and differentiation
syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols. Breccia M,
Mazzarella L, Bagnardi V, Disalvatore D, Loglisci G, Cimino G, Testi AM, Avvisati G, Petti MC, Minotti
C, Latagliata R, Foà R, Pelicci PG, Lo-Coco F.Blood. 2011 Nov 9.
236. IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy. Pisani F,
Petrucci MT, Giannarelli D, Bongarzoni V, Montanaro M, De Stefano V, La Verde G, Gentilini F, Levi A,
Za T, Moscetti A, Annino L, Petti MC. J Exp Clin Cancer Res. 2012 Mar 1;31(1):17.
Intensive consolidation therapy compared with standard consolidation and maintenance therapy for
adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized
phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer
(EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia
Cooperative Groups. Hengeveld M, Suciu S, Karrasch M, Specchia G, Marie JP, Muus P, Petti MC,
Rotoli B, Amadori S, Fioritoni G, Leoni P, Morra E, Thaler J, Resegotti L, Fazi P, Vignetti M, Mandelli F,
Zittoun R, de Witte T. Ann Hematol. 2012 Jun;91(6):825-35.
237. Bortezomib-based therapy increases the incidence of post-transplant Cytomegalovirus
reactivations in Multiple Myeloma patients undergoing autologous stem cell transplantation: a survey
from the Rome Transplant Network. F. Marchesi, A. Mengarelli, F. Giannotti, A. Tendas, B. Anaclerico,
R. Porrini, A. Picardi, E. Cerchiara, T. Dentamaro, A. Chierichini, A. Romeo, L. Cudillo, E. Montefusco,
M.C. Tirindelli, P. De Fabritiis, L. Annino, Petti M.C., B. Monarca, W. Arcese, G. Avvisati, for the Rome
Transplant Network. Transplant Infectious Disease. Accepted for publication, 13-05-2013.
238. Cross-recognition of aspergillus galactomannan caused by Listeria monocytogenes infection.
Petti MC1, Prignano G, Mengarelli A, Spadea A, Cilli L, Girmenia C. Diagn Microbiol Infect Dis. 2013
Jun;76(2):250-1.
239. A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin
lymphoma: clinical significance of treatment intensity and comprehensive geriatric assessment.
Marchesi F1, Cenfra N, Altomare L, Dessanti ML, Mecarocci S, Cerchiara E, Rago A, D'Andrea M,
Tomarchio V, Olimpieri OM, Tirindelli MC, Mengarelli A, Petti MC, Avvisati G, Cimino G. J Geriatr
Oncol. 2013 Jul;4(3):242-8.
240. High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing
autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from
the Rome Transplant Network. Marchesi F1, Mengarelli A, Giannotti F, Tendas A, Anaclerico B, Porrini
R, Picardi A, Cerchiara E, Dentamaro T, Chierichini A, Romeo A, Cudillo L, Montefusco E, Tirindelli
MC, De Fabritiis P, Annino L, Petti MC, Monarca B, Arcese W, Avvisati G; Rome Transplant Network.
Transpl Infect Dis. 2014 Feb;16(1):158-64.
Projects
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 22 / 23
Curriculum Vitae
Memberships
Other Relevant Information
Maria Concetta Petti
Member Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES),
European Society of Hematology (EHA), European Bone Marrow Transplantation (EBMT)
Professor at Post graduate School of Hematology University "la Sapienza" 1991-2007
Professor at Post graduate School of Hematology Campus Biomedico Rome 2002-2012
Professor at Post graduate School of Gastroenterology University "La Sapienza" 1998-2008
20/6/14
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 23 / 23
Download
Related flashcards

Orthopedics

21 cards

Hygiene

25 cards

Medical treatments

33 cards

History of medicine

34 cards

Surgery

45 cards

Create Flashcards